DISORDER OF LIPID METABOLISM IN CHRONIC KIDNEY DISEASE
DOI:
https://doi.org/10.47390/3030-3133V5I4Y2024N01Keywords:
Periodontitis, diabetes, hyperglycemia, inflammation, oral microflora, immune response, glycemic control, periodontal care, vascular changes.Abstract
Chronic kidney disease is a proven risk factor for the development and progression of lipid metabolism disorders. These disorders are based on an increase in the blood plasma content of cholesterol, triglycerides, low—density lipoproteins and a decrease in the level of high-density lipoproteins, apoproteins of the A family (ApoA-I and ApoA-II). There is a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol-acetyltransferase.
References
Адабиётлар/Литература/References
Chen S.C., Hung C.C., Kuo M.C. et al. Association of dyslipidemia with renal outcomes inchronic kidney disease // PLoS One. — 2013. — № 8(2). — Е55643.
Colina I.B. Hyperli pidemia in patients with chronic kidney disease: features andapproaches to treatment // The attending physician. — 2012. — № 1. — Р. 63-70.
Colina I.B., Stavrovskaya U., Shilov E.M. Dysli pidemia, and chronic progressive renaldisease // Ter. archive. — 2004. — № 76(9). — Р. 75-8.
El Nahas A.M., Bello A.K. Chronic kidney disease: The global challenge // Lancet. — 2005.— № 365. — Р. 331-40.
Gröne E.F., Gröne H.J. Does hyperli pidemia injure the kidney? Nature clinical practice //Nephrology. — 2008. — № 4(8). — Р. 424-5.
Grone H.J., Walli A., Grone E., Niedmann P., Thiery J., Seidel D., Helmchen U. Induction ofglomerulosclerosis by dietary lipids. A functional and morphologic study in the rat // Lab.Invest. — 1989. — № 60. — Р. 433-46.
Jabbarov, O. O. "Disorders Function of the Heart and Kidney in Diabetes Mellitus." (2023).
Jabbarov, O. O., A. A. Imamov, N. K. Khuzhaniyazova, L. D. Tursunova, and O. AtakhanovaSh. "Pathogenetic Factors Development of Diabetic Nephropathy." (2023).
Jay V. Richard Bright: physician extraordinaire // Arch. Pathol. Lab. Med. — 2000. — №124.— Р. 1262-1263.
Keane W.F. Lipids and the kidney // Kidney International. — 1994. — № 46(3). — Р. 910-20.
Keane W.F., O’Donnell M.P., Kasiske B.L. Oxidative modification of low-densitylipoproteins by mesangial cells // Journal of the American Society of Nephrology. — 1993.— № 4. — Р. 187-94.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012Clinical Proctice Guideline for the Evaluation and Management of Chronic Kidney Disease// Kidney Int. — 2013. — 3(Suppl.). — Р. 1-150.
Kume S., Uzu T., Araki S. et al. Role of altered renal lipid metabolism in the developmentof renal injury induced by a high-fat diet // Journal of the American Society of Nephrology.— 2007. — № 18. — Р. 2715-23.
Levey A.S., Atkins R., Coresh J. et al. Chronic kidney disease as a global public healthproblem: Approaches and initiatives — A position statement from Kidney DiseaseImproving Global Outcomes // Kidney Int. — 2007. — № 72. — Р. 247-59.
